Rachel E.Page

Rachel Page focuses her practice on the representation of health care and life sciences companies. She represents hospitals, health systems, physician group practices, hospice providers, pharmaceutical and medical device manufacturers, and emerging and established companies in the digital health and health technology sectors.

Rachel counsels clients on regulatory and compliance issues, including federal and state anti-kickback statutes, reimbursement, the Physician Payments Sunshine Act (Open Payments), compliance program development and assessment, clinical research and U.S. Food & Drug Administration (FDA) regulations, licensure, direct-to-consumer telemedicine and telehealth, and state corporate practice of medicine doctrines. She also defends health care and life sciences clients in investigations and litigation relating to the False Claims Act, the federal Anti-Kickback Statute, and the Stark Law brought by federal agencies and qui tam whistleblowers and assists in conducting internal investigations and developing repayment strategies.

She handles transactional matters for clients, advising on structural considerations, diligence, and risk mitigation strategies for a variety of transactions, including hospital, hospice, home health, and physician practice acquisitions; private equity investments; and corporate and commercial arrangements in the life sciences industry.

Prior to attending law school, Rachel worked in the legal and compliance department for a regional health insurance company during the implementation of the Affordable Care Act. She is a member of the American Health Lawyers Association and the Illinois Association of Healthcare Attorneys. In 2022, Rachel received the Law360 Rising Star Award in Health Care, which is awarded to the "top attorneys under 40" whose legal accomplishments transcend their age.